Philips introduces Affiniti CVx and Release 7.0 of EPIQ CVx with breakthrough interventional and productivity features to support cardiology departments managing everyday challenges Amsterdam ...

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced today the latest addition to its portfolio of dedicated cardiovascular ultrasound solutions – Affiniti CVx – [1] ...

At ESC 2020, Philips debuts its new Affiniti CVx and release 7.0 for EPIQ CVx cardiovascular ultrasound solutions, which include improvements to enhance confidence in diagnosis and procedures ...